Filing Details

Accession Number:
0001203311-12-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-24 19:30:47
Reporting Period:
2012-04-20
Filing Date:
2012-04-24
Accepted Time:
2012-04-24 19:30:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seattle Genetics Inc SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202786 Morris Rosenberg 21823 30Th Drive Se
Bothell WA 98021
Evp, Process Sciences No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-20 38,281 $5.63 55,924 No 4 M Direct
Common Stock Disposition 2012-04-20 38,281 $19.51 17,643 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-04-20 38,281 $0.00 38,281 $5.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-01-31 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Rosenberg on March 15, 2012.
  2. Amount of securities beneficially owned following reported transactions includes 17,643 Restricted Stock Units subject to vesting.
  3. Shares shall vest at a rate of 25% on 1/31/07 and monthly thereafter until all the shares are fully vested on 1/31/10.